Article Text

Download PDFPDF
White Owl launches sweepstakes to promote new dessert-flavoured cigar
  1. Zeinab Safi1,
  2. Ollie Ganz1,2,
  3. Daniel P Giovenco3,
  4. Cristine Delnevo1,2,
  5. M Jane Lewis1,2
  1. 1 Rutgers Biomedical and Health Sciences, Rutgers Center for Tobacco Studies, New Brunswick, New Jersey, USA
  2. 2 Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, New Jersey, USA
  3. 3 Sociomedical Sciences, Columbia University Mailman School of Public Health, New York, New York, USA
  1. Correspondence to Zeinab Safi, Rutgers Biomedical and Health Sciences, Rutgers Center for Tobacco Studies, New Brunswick, New Jersey, USA; zs323{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Since 2009, flavours other than menthol have been prohibited in cigarettes in the USA.1 Meanwhile, flavours remain available in other tobacco products, such as cigars, and continue to be produced and sold in the USA. In recent years, cigar sales have risen;2 notably, sales of flavoured cigars have increased by nearly 50% since the signing of the Tobacco Control Act.3 In 2018, the Food and Drug Administration announced their intent to move forward with proposed rulemaking to ban menthol in cigarettes and all flavours in cigars; however, action has yet to be taken following this announcement.4 As such, cigar manufacturers have taken advantage of the lack of regulation and continue to create flavoured products that appeal to young people.5

White Owl is a cigar brand owned by Swedish Match North America and promotes a wide range …

View Full Text


  • Twitter @otg2014, @dannygiovenco

  • Contributors OG and CD conceptualised the idea. ZS led the writing of the first draft and OG, DPG, CD and MJL provided input on subsequent drafts. All authors contributed equally and have approved the final manuscript.

  • Funding This work was supported in part by National Cancer Institute and Food and Drug Administration Center for Tobacco Products under grant U54CA229973. OG was supported by the Rutgers Cancer Institute of New Jersey under grant P30CA07270. DPG was supported by a grant from the NIH Office of the Director (award number DP5OD023064).

  • Disclaimer The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or FDA.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.